Katz MH - Search Results

1

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Roland ME, et al. Among authors: katz mh. J Infect Dis. 2001 Dec 15;184(12):1608-12. doi: 10.1086/324580. Epub 2001 Dec 3. J Infect Dis. 2001. PMID: 11740738

2

HIV RNA testing in the context of nonoccupational postexposure prophylaxis.

Roland ME, Elbeik TA, Kahn JO, Bamberger JD, Coates TJ, Krone MR, Katz MH, Busch MP, Martin JN. Roland ME, et al. Among authors: katz mh. J Infect Dis. 2004 Aug 1;190(3):598-604. doi: 10.1086/421278. Epub 2004 Jul 7. J Infect Dis. 2004. PMID: 15243937

3

Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States.

Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Pinkerton SD, et al. Among authors: katz mh. AIDS. 2004 Oct 21;18(15):2065-73. doi: 10.1097/00002030-200410210-00011. AIDS. 2004. PMID: 15577628

4

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN. Roland ME, et al. Among authors: katz mh. Clin Infect Dis. 2005 Nov 15;41(10):1507-13. doi: 10.1086/497268. Epub 2005 Oct 13. Clin Infect Dis. 2005. PMID: 16231265 Clinical Trial.

5

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.

Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Pinkerton SD, et al. Among authors: katz mh. Arch Intern Med. 2004 Jan 12;164(1):46-54. doi: 10.1001/archinte.164.1.46. Arch Intern Med. 2004. PMID: 14718321

6

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, Chesney MA, Franses K, Kahn JO, Coates TJ, Katz MH. Martin JN, et al. Among authors: katz mh. AIDS. 2004 Mar 26;18(5):787-92. doi: 10.1097/00002030-200403260-00010. AIDS. 2004. PMID: 15075514 Clinical Trial.

7

Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault.

Bamberger JD, Waldo CR, Gerberding JL, Katz MH. Bamberger JD, et al. Among authors: katz mh. Am J Med. 1999 Mar;106(3):323-6. doi: 10.1016/s0002-9343(99)00018-2. Am J Med. 1999. PMID: 10190382 Review.

8

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH. Kahn JO, et al. Among authors: katz mh. J Infect Dis. 2001 Mar 1;183(5):707-14. doi: 10.1086/318829. Epub 2001 Feb 1. J Infect Dis. 2001. PMID: 11181146

9

Helping the urban poor stay with antiretroviral HIV drug therapy.

Bamberger JD, Unick J, Klein P, Fraser M, Chesney M, Katz MH. Bamberger JD, et al. Among authors: katz mh. Am J Public Health. 2000 May;90(5):699-701. doi: 10.2105/ajph.90.5.699. Am J Public Health. 2000. PMID: 10800416 Free PMC article.

10

Postexposure prophylaxis for HIV after sexual assault.

Myles JE, Hirozawa A, Katz MH, Kimmerling R, Bamberger JD. Myles JE, et al. Among authors: katz mh. JAMA. 2000 Sep 27;284(12):1516-8. doi: 10.1001/jama.284.12.1516-a. JAMA. 2000. PMID: 11000643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

748 results

Search Page

Filters